Kevin J. Mcnamara Sells 1,000 Shares of Chemed Co. (NYSE:CHE) Stock

Chemed Co. (NYSE:CHE) CEO Kevin J. Mcnamara sold 1,000 shares of the stock in a transaction dated Monday, March 31st. The stock was sold at an average price of $615.33, for a total value of $615,330.00. Following the transaction, the chief executive officer now owns 101,679 shares of the company’s stock, valued at approximately $62,566,139.07. The trade was a 0.97 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link.

Chemed Stock Performance

Shares of NYSE CHE opened at $614.41 on Thursday. The stock has a 50 day moving average price of $577.76 and a 200 day moving average price of $567.62. The stock has a market capitalization of $8.99 billion, a PE ratio of 31.05, a price-to-earnings-growth ratio of 2.15 and a beta of 0.43. Chemed Co. has a 52 week low of $512.12 and a 52 week high of $639.61.

Chemed Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Monday, February 24th were issued a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 0.33%. The ex-dividend date was Monday, February 24th. Chemed’s payout ratio is presently 10.05%.

Hedge Funds Weigh In On Chemed

A number of institutional investors have recently added to or reduced their stakes in CHE. UMB Bank n.a. grew its position in shares of Chemed by 300.0% in the 4th quarter. UMB Bank n.a. now owns 52 shares of the company’s stock valued at $28,000 after acquiring an additional 39 shares during the period. Atala Financial Inc bought a new position in Chemed during the fourth quarter worth about $29,000. CBIZ Investment Advisory Services LLC increased its position in Chemed by 64.7% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company’s stock worth $30,000 after buying an additional 22 shares during the last quarter. Trust Co. of Vermont bought a new stake in Chemed in the fourth quarter valued at approximately $34,000. Finally, Tortoise Investment Management LLC lifted its position in shares of Chemed by 77.3% in the fourth quarter. Tortoise Investment Management LLC now owns 78 shares of the company’s stock valued at $41,000 after buying an additional 34 shares during the last quarter. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on CHE shares. Royal Bank of Canada raised their price target on shares of Chemed from $633.00 to $667.00 and gave the stock an “outperform” rating in a research note on Friday, March 14th. StockNews.com raised shares of Chemed from a “hold” rating to a “buy” rating in a research report on Friday, March 7th.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.